PrtR homeostasis contributes to Pseudomonas aeruginosa pathogenesis and resistance against Ciprofloxacin

Infection and Immunity

Volumn 82, Issue 4, 2014, Pages 1638-1647

  Sun, Ziyu ^a   Shi, Jing ^a   Liu, Chang ^a   Jin, Yongxin ^a   Li, Kewei ^a   Chen, Ronghao ^a   Jin, Shouguang ^a,b   Wu, Weihui ^a  

^a NANKAI UNIVERSITY   (China)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CIPROFLOXACIN; HYDROGEN PEROXIDE; PRTR PROTEIN; PYOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DNA REPAIR; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HOMEOSTASIS; HOST CELL; LOBAR PNEUMONIA; LUNG LAVAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PSEUDOMONAS AERUGINOSA; TYPE III SECRETION SYSTEM;

ACUTE DISEASE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOFILMS; BRONCHOALVEOLAR LAVAGE FLUID; CIPROFLOXACIN; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HOMEOSTASIS; HYDROGEN PEROXIDE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PYOCINS; REACTIVE OXYGEN SPECIES; REPRESSOR PROTEINS; RNA, MESSENGER;

EID: 84896482571     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01388-13     Document Type: Article

References (46)

1. Riley MA, Wertz JE. 2002. Bacteriocins: evolution, ecology, and application. Annu. Rev. Microbiol. 56:117-137. http://dx.doi.org/10.1146/annurev.micro.56.012302.161024.
2. Zgur-Bertok D. 2012. Regulating colicin synthesis to cope with stress and lethality of colicin production. Biochem. Soc. Trans. 40:1507-1511. http://dx.doi.org/10.1042/BST20120184.
3. Driscoll JA, Brody SL, Kollef MH. 2007. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67:351-368. http://dx.doi.org/10.2165/00003495-200767030-00003.
4. Michel-Briand Y, Baysse C. 2002. The pyocins of Pseudomonas aeruginosa. Biochimie 84:499-510. http://dx.doi.org/10.1016/S0300-9084(02)01422-0.
5. Waite RD, Curtis MA. 2009. Pseudomonas aeruginosa PAO1 pyocin production affects population dynamics within mixed-culture biofilms. J. Bacteriol. 191:1349-1354. http://dx.doi.org/10.1128/JB.01458-08.
6. Bakkal S, Robinson SM, Ordonez CL, Waltz DA, Riley MA. 2010. Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients. Microbiology 156:2058-2067. http://dx.doi.org/10.1099/mic.0.036848-0.
7. Matsui H, Sano Y, Ishihara H, Shinomiya T. 1993. Regulation of pyocin genes in Pseudomonas aeruginosa by positive (prtN) and negative (prtR) regulatory genes. J. Bacteriol. 175:1257-1263.
8. Brazas MD, Hancock RE. 2005. Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:3222-3227. http://dx.doi.org/10.1128/AAC.49.8.3222-3227.2005.
9. Chang W, Small DA, Toghrol F, Bentley WE. 2005. Microarray analysis of Pseudomonas aeruginosa reveals induction of pyocin genes in response to hydrogen peroxide. BMC Genomics 6:115. http://dx.doi.org/10.1186/1471-2164-6-115.
10. Kolpen M, Hansen CR, Bjarnsholt T, Moser C, Christensen LD, van Gennip M, Ciofu O, Mandsberg L, Kharazmi A, Doring G, Givskov M, Hoiby N, Jensen PO. 2010. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 65:57-62. http://dx.doi.org/10.1136/thx.2009.114512.
11. Tamma PD, Cosgrove SE, Maragakis LL. 2012. Combination therapy for treatment of infections with gram-negative bacteria. Clin. Microbiol. Rev. 25:450-470. http://dx.doi.org/10.1128/CMR.05041-11.
12. Wu W, Jin S. 2005. PtrB of Pseudomonas aeruginosa suppresses the type III secretion system under the stress of DNA damage. J. Bacteriol. 187: 6058-6068. http://dx.doi.org/10.1128/JB.187.17.6058-6068.2005.
13. Diaz MH, Shaver CM, King JD, Musunuri S, Kazzaz JA, Hauser AR. 2008. Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect. Immun. 76:4414-4421. http://dx.doi.org/10.1128/IAI.00012-08.
14. Diaz MH, Hauser AR. 2010. Pseudomonas aeruginosa cytotoxin ExoU is injected into phagocytic cells during acute pneumonia. Infect. Immun. 78:1447-1456. http://dx.doi.org/10.1128/IAI.01134-09.
15. Howell HA, Logan LK, Hauser AR. 2013. Type III secretion of ExoU is critical during early Pseudomonas aeruginosa pneumonia. mBio 4:e00032-13. http://dx.doi.org/10.1128/mBio.00032-13.
16. Wu W, Huang J, Duan B, Traficante DC, Hong H, Risech M, Lory S, Priebe GP. 2012. Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 186:420-427. http://dx.doi.org/10.1164/rccm.201202-0182OC.
17. Lane MC, Lockatell V, Monterosso G, Lamphier D, Weinert J, Hebel JR, Johnson DE, Mobley HL. 2005. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect. Immun. 73: 7644-7656. http://dx.doi.org/10.1128/IAI.73.11.7644-7656.2005.
18. Champion OL, Cooper IA, James SL, Ford D, Karlyshev A, Wren BW, Duffield M, Oyston PC, Titball RW. 2009. Galleria mellonella as an alternative infection model for Yersinia pseudotuberculosis. Microbiology 155:1516-1522. http://dx.doi.org/10.1099/mic.0.026823-0.
19. Chen A, Seifert HS. 2011. Neisseria gonorrhoeae-mediated inhibition of apoptotic signalling in polymorphonuclear leukocytes. Infect. Immun. 79:4447-4458. http://dx.doi.org/10.1128/IAI.01267-10.
20. Wu W, Hsu YM, Bi L, Songyang Z, Lin X. 2009. CARD9 facilitates microbe-elicited production of reactive oxygen species by regulating the LyGDI-Rac1 complex. Nat. Immunol. 10:1208-1214. http://dx.doi.org/10.1038/ni.1788.
21. Bertram R, Rigali S, Wood N, Lulko AT, Kuipers OP, Titgemeyer F. 2011. Regulon of the N-acetylglucosamine utilization regulator NagR in Bacillus subtilis. J. Bacteriol. 193:3525-3536. http://dx.doi.org/10.1128/JB.00264-11.
22. Brencic A, McFarland KA, McManus HR, Castang S, Mogno I, Dove SL, Lory S. 2009. The GacS/GacA signal transduction system of Pseudomonas aeruginosa acts exclusively through its control over the transcription of the RsmY and RsmZ regulatory small RNAs. Mol. Microbiol. 73:434-445. http://dx.doi.org/10.1111/j.1365-2958.2009.06782.x.
23. Liao J, Schurr MJ, Sauer K. 2013. The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms. J. Bacteriol. 195:3352-3363. http://dx.doi.org/10.1128/JB.00318-13.
24. Billings N, Millan M, Caldara M, Rusconi R, Tarasova Y, Stocker R, Ribbeck K. 2013. The extracellular matrix component Psl provides fastacting antibiotic defense in Pseudomonas aeruginosa biofilms. PLoS Pathog. 9:e1003526. http://dx.doi.org/10.1371/journal.ppat.1003526.
25. Bjerkan G, Witso E, Bergh K. 2009. Sonication is superior to scraping for retrieval of bacteria in biofilm on titanium and steel surfaces in vitro. Acta Orthop. 80:245-250. http://dx.doi.org/10.3109/17453670902947457.
26. Priebe GP, Walsh RL, Cederroth TA, Kamei A, Coutinho-Sledge YS, Goldberg JB, Pier GB. 2008. IL-17 is a critical component of vaccineinduced protection against lung infection by lipopolysaccharideheterologous strains of Pseudomonas aeruginosa. J. Immunol. 181:4965-4975. http://www.jimmunol.org/content/181/7/4965.
27. Craig A, Mai J, Cai S, Jeyaseelan S. 2009. Neutrophil recruitment to the lungs during bacterial pneumonia. Infect. Immun. 77:568-575. http://dx.doi.org/10.1128/IAI.00832-08.
28. Dubin PJ, Martz A, Eisenstatt JR, Fox MD, Logar A, Kolls JK. 2012. Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection. Infect. Immun. 80:398-409. http://dx.doi.org/10.1128/IAI.05821-11.
29. Power MR, Peng Y, Maydanski E, Marshall JS, Lin TJ. 2004. The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. J. Biol. Chem. 279:49315-49322. http://dx.doi.org/10.1074/jbc.M402111200.
30. Aoshiba K, Nakajima Y, Yasui S, Tamaoki J, Nagai A. 1999. Red blood cells inhibit apoptosis of human neutrophils. Blood 93:4006-4010.
31. Winterbourn CC, Stern A. 1987. Human red cells scavenge extracellular hydrogen peroxide and inhibit formation of hypochlorous acid and hydroxyl radical. J. Clin. Invest. 80:1486-1491. http://dx.doi.org/10.1172/JCI113230.
32. van Asbeck BS, Hoidal J, Vercellotti GM, Schwartz BA, Moldow CF, Jacob HS. 1985. Protection against lethal hyperoxia by tracheal insufflation of erythrocytes: role of red cell glutathione. Science 227:756-759. http://dx.doi.org/10.1126/science.2982213.
33. Toth KM, Clifford DP, Berger EM, White CW, Repine JE. 1984. Intact human erythrocytes prevent hydrogen peroxide-mediated damage to isolated perfused rat lungs and cultured bovine pulmonary artery endothelial cells. J. Clin. Invest. 74:292-295. http://dx.doi.org/10.1172/JCI111414.
34. Agar NS, Sadrzadeh SM, Hallaway PE, Eaton JW. 1986. Erythrocyte catalase. A somatic oxidant defense? J. Clin. Invest. 77:319-321.
35. Brown JM, Grosso MA, Terada LS, Beehler CJ, Toth KM, Whitman GJ, Harken AH, Repine JE. 1989. Erythrocytes decrease myocardial hydrogen peroxide levels and reperfusion injury. Am. J. Physiol. 256:H584-588.
36. Carratala J, Roson B, Fernandez-Sevilla A, Alcaide F, Gudiol F. 1998. Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome. Arch. Intern. Med. 158:868-872. http://dx.doi.org/10.1001/archinte.158.8.868.
37. Secher T, Fas S, Fauconnier L, Mathieu M, Rutschi O, Ryffel B, Rudolf M. 2013. The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem. PLoS One 8:e73396. http://dx.doi.org/10.1371/journal.pone.0073396.
38. Kamei A, Wu W, Traficante DC, Koh AY, Van Rooijen N, Pier GB, Priebe GP. 2013. Collaboration between macrophages and vaccineinduced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia. J. Infect. Dis. 207:39-49. http://dx.doi.org/10.1093/infdis/jis657.
39. Wink DA, Hines HB, Cheng RY, Switzer CH, Flores-Santana W, Vitek MP, Ridnour LA, Colton CA. 2011. Nitric oxide and redox mechanisms in the immune response. J. Leukoc. Biol. 89:873-891. http://dx.doi.org/10.1189/jlb.1010550.
40. Stayrook S, Jaru-Ampornpan P, Ni J, Hochschild A, Lewis M. 2008. Crystal structure of the lambda repressor and a model for pairwise cooperative operator binding. Nature 452:1022-1025. http://dx.doi.org/10.1038/nature06831.
41. Hochschild A, Lewis M. 2009. The bacteriophage lambda CI protein finds an asymmetric solution. Curr. Opin. Struct. Biol. 19:79-86. http://dx.doi.org/10.1016/j.sbi.2008.12.008.
42. Olsen RH, DeBusscher G, McCombie WR. 1982. Development of broadhost-range vectors and gene banks: self-cloning of the Pseudomonas aeruginosa PAO chromosome. J. Bacteriol. 150:60-69.
43. Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86. http://dx.doi.org/10.1016/S0378-1119(98)00130-9.
44. Choi KH, Schweizer HP. 2006. mini-Tn7 insertion in bacteria with single attTn7 sites: example Pseudomonas aeruginosa. Nat. Protoc. 1:153-161. http://dx.doi.org/10.1038/nprot.2006.24.
45. Choi KH, Gaynor JB, White KG, Lopez C, Bosio CM, Karkhoff-Schweizer RR, Schweizer HP. 2005. A Tn7-based broad-range bacterial cloning and expression system. Nat. Methods 2:443-448. http://dx.doi.org/10.1038/nmeth765.
46. Li K, Xu C, Jin Y, Sun Z, Liu C, Shi J, Chen G, Chen R, Jin S, Wu W. 2013. SuhB is a regulator of multiple virulence genes and essential for pathogenesis of Pseudomonas aeruginosa. mBio 4:e00419-13. http://dx.doi.org/10.1128/mBio.00419-13.